VGI Health Technology (XNEC:VTL) Net Margin % : 0.00% (As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. VGI Health Technology's Net Income for the six months ended in . 20 was A$0.00 Mil. VGI Health Technology's Revenue for the six months ended in . 20 was A$0.00 Mil. Therefore, VGI Health Technology's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for VGI Health Technology's Net Margin % or its related term are showing as below:

XNEC:VTL's Net Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -154.15
* Ranked among companies with meaningful Net Margin % only.

VGI Health Technology Net Margin % Historical Data

The historical data trend for VGI Health Technology's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology Net Margin % Chart

VGI Health Technology Annual Data

Trend

Net Margin %

VGI Health Technology Semi-Annual Data

Net Margin %

Competitive Comparison of VGI Health Technology's Net Margin %

For the Biotechnology subindustry, VGI Health Technology's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VGI Health Technology's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VGI Health Technology's Net Margin % distribution charts can be found below:

* The bar in red indicates where VGI Health Technology's Net Margin % falls into.

VGI Health Technology Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

VGI Health Technology's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin	=	Net Income (A: . 20 )	/	Revenue (A: . 20 )
	=		/
	=	%

VGI Health Technology's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin	=	Net Income (Q: . 20 )	/	Revenue (Q: . 20 )
	=		/
	=	%

VGI Health Technology (XNEC:VTL) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

VGI Health Technology Net Margin % Related Terms

Thank you for viewing the detailed overview of VGI Health Technology's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

VGI Health Technology (XNEC:VTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003

Website

https://www.vgiht.com

VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines